Ostrum Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Ostrum Asset Management's BMY Position: Q2 2026 in Review

Ostrum Asset Management increased its Bristol-Myers Squibb (BMY) stake by 14% in Q2 2026, buying an estimated $432K and bringing the position to 61,627 shares worth $3.55M. The position accounts for 0.17% of the portfolio, ranked #84.

Ostrum Asset Management first reported a position in BMY in Q1 2023 and has held it in 14 quarters since. The position peaked at $7.46M in Q1 2023. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

• Ostrum Asset Management held 61,627 shares of Bristol-Myers Squibb worth $3.55M as of Q2 2026.
• Ostrum Asset Management bought 7,529 Bristol-Myers Squibb shares in Q2 2026, an estimated $432K.
• Bristol-Myers Squibb made up 0.17% of Ostrum Asset Management's portfolio in Q2 2026, its #84 holding.
• Ostrum Asset Management first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 14 quarters since.
• Ostrum Asset Management's Bristol-Myers Squibb position peaked at $7.46M in Q1 2023.
• 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Ostrum Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.